跳至主要内容
临床试验/ISRCTN18435077
ISRCTN18435077已完成不适用

Realisation of established targets for patients with diabetes type 2 at primary care setting

Aventis (The Netherlands)0 个研究点目标入组 500 人开始时间: 2005年12月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Patients with type 2 diabetes
  • 2. Signed informed consent

排除标准

  • 1. Aged less than 18 years
  • 2. Quality-adjusted life years (QALY) less than 5 years
  • 3. Use of insulin, fibrates or thiazolidines less than 6 weeks before inclusion
  • 4. Heart failure, New York Heart Association (NYHA) class II or more
  • 5. Myocardial infarction (MI), angina pectoris (AP), transient ischaemic attack (TIA) or cerebrovascular attack (CVA) less than 3 months before randomisation
  • 6. Surgery, severe trauma or infection less than 3 months before randomisation
  • 7. Known liver disease or alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma glutamyltransferase (GT) greater than three times upper limit
  • 8. Serum creatinine greater than 150 mmol/l
  • 9. Triglycerides greater than 8 mmol/l

研究者

发起方
Aventis (The Netherlands)

相似试验